CYNO News 24.77 Cynosure Inc (CYNO)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cynosure Inc (CYNO) 24.77 $CYNO

Cynosure Shares Down 11.1% Since SmarTrend's Sell Call (CYNO)
Comtex SmarTrend(R) - Fri Apr 11, 10:17AM CDT
SmarTrend identified a Downtrend for Cynosure (NASDAQ:CYNO) on March 20th, 2014 at $29.39. In approximately 3 weeks, Cynosure has returned 11.08% as of today's recent price of $26.13.

AngioDynamics Q3 Earnings Flat but Beat Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 8:28AM CDT
ANGO lowered its adjusted EPS guidance for fiscal 2014 to a range of 60 to 63 cents from the prior range of 63 to 67 cents.

Delcath Systems (DCTH) Worth Watching: Stock Soars 20.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 8:25AM CDT
Delcath Systems was a big mover last session, with shares surging over 20% on the day.

Masimo Reports Encouraging PVI Study Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 5:40PM CDT
The results demonstrated that MASI's non-invasive PVI parameter helps clinicians optimize fluid administration for abdominal surgical patients under combined general and epidural anesthesia.

Delcath Systems Shares Tank on Stock Split - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 1:50PM CDT
Delcath has been going through a rough patch after it failed to win approval from U.S. Food and Drug Administration (FDA) for its Melblez liver cancer therapy device.

Financial Results Announcement, Stock Movement, Presentations, and Acquisition - Analyst Notes on Universal Health Services, Tenet, Cynosure, Albany Molecular Research, and Enanta
PR Newswire - Thu Apr 10, 9:49AM CDT
Today, Analysts Review released its analysts' notes regarding Universal Health Services, Inc. (NYSE: UHS), Tenet Healthcare Corp. (NYSE: THC), Cynosure, Inc. (NASDAQ: CYNO), Albany Molecular Research Inc. (NASDAQ: AMRI), and Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Cepheid (CPHD) Looks Good: Stock Adds 5.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 8:04AM CDT
Cepheid was a big mover last session, as the company saw its shares rise over 5% on the day.

Intuitive Surgical (ISRG) Crumbles: Stock Falls by 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 7:34AM CDT
Shares of Intuitive Surgical fell nearly 7% on the day. This continues the recent trend of the company, as the stock is now trading within the volatile price range of $422.1 to $540.6 in the past one-month time frame.

Varian Medical Systems Closes Velocity Software Acquisition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 2:20PM CDT
Post-acquisition, VAR expects its global sales, service and support network to contribute to faster and deeper market penetration for the Velocity product.

Intuitive Surgical Expects Lower Q1 Revs, Shares Dip - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 1:50PM CDT
Per Intuitive Surgical, the deferrals will reduce Systems revenues by roughly $24 million and Instruments and Accessories revenues by $2 million.

Echo Therapeutics Slips to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 07, 1:50PM CDT
Echo Therapeutics' fourth-quarter reported loss per share more than doubled year over year to $3.9 million or 36 cents.

Thoratec Slapped with Class I Recall for HeartMate Controller - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 12:20PM CDT
THOR initiated its recall of HeartMate II left ventricular assist device (LVAD) after sending safety advisory to hospitals regarding the use of its pocket system controller for the device.

Intuitive Surgical Recalls Cannulae, Shares Shoot Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 3:35PM CDT
Intuitive Surgical stated that if inspection reveals damaged devices, they should be quarantined and returned to the company for replacement

DexCom Shares Fall on FDA Warning - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 2:30PM CDT
Since the revelation of the warning letter, DexCom's shares dropped 5.7% to close at $41.95 yesterday.

New Taker for Varian's PerfectPitch Couch - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 02, 5:40PM CDT
The PerfectPitch robotic couch has been introduced by the hospital as an integrated element of VAR's latest TrueBeam 2.0 system used to optimize radiotherapy treatments.

FDA Clears Intuitive Surgical's New da Vinci System - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 02, 2:10PM CDT
Intuitive Surgical revealed that the new robotic system, known as da Vinci Xi, has longer instrument shafts enabling greater reach for surgery

Intuitive Surgical (ISRG) in Focus: Stock Rises 12.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 02, 8:25AM CDT
Intuitive Surgical was a big mover last session, with shares rising nearly 13% on the day.

Cynosure Announces 35 Clinical Research Presentations at 34th ASLMS Annual Conference
PR Newswire - Wed Apr 02, 7:30AM CDT
Cynosure, Inc. (NASDAQ: CYNO) today announced that 21 oral abstracts and 14 e-posters are scheduled for presentation this week at LASER 2014, the 34th Annual Scientific Conference of the American Society for Laser Medicine and Surgery (ASLMS). LASER 2014 takes place today through April 6 at the Phoenix Convention Center/Sheraton Phoenix Downtown Hotel in Phoenix, Arizona.

Study: Teleflex Catheter Reduces Costs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 6:20PM CDT
The study, conducted by Leonardo Lorente M.D., Ph.D. and his colleagues independently, found that the Teleflex's ARROW catheter with ARROWg+ard Blue PLUS Technology lowers the risk of catheter-related bloodstream infections.

Teleflex Raised to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 1:50PM CDT
An encouraging guidance, increased M&A activity and stronger operating leverage represent a potential upside for Teleflex going forward.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 250

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 88

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 273

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 241

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 322

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 393

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 47

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
IS: Thai Approval Opens New Sarcoma Treatment Path"> Continue Reading